The Oncology Institute Inc
(TOI)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 393,412 | 324,239 | 252,483 | 203,003 | 187,515 |
| Cost of Goods | 339,415 | 264,666 | 200,390 | 162,155 | 150,636 |
| Gross Profit | 53,997 | 59,573 | 52,093 | 40,848 | 36,879 |
| Operating Expenses | 114,530 | 137,257 | 134,434 | 86,861 | 45,712 |
| Operating Income | -60,118 | -77,018 | -81,951 | -45,858 | -8,197 |
| Interest Expense | 7,496 | 6,777 | 4,082 | 320 | 347 |
| Other Income | 2,951 | 691 | 85,942 | 34,580 | -6,271 |
| Pre-tax Income | -64,663 | -83,104 | -91 | -11,598 | -14,815 |
| Income Tax | N/A | -36 | -243 | -671 | -493 |
| Net Income Continuous | -64,663 | -83,068 | 152 | -10,927 | -14,322 |
| Net Income | $-64,663 | $-83,068 | $152 | $-10,927 | $-14,322 |
| EPS Basic Total Ops | -0.71 | -0.92 | 0.00 | -0.16 | -0.24 |
| EPS Basic Continuous Ops | -0.86 | -1.13 | 0.00 | -0.17 | -0.24 |
| EPS Diluted Total Ops | -0.71 | -0.92 | -0.21 | -0.16 | -0.24 |
| EPS Diluted Continuous Ops | -0.86 | -1.13 | 0.00 | -0.17 | -0.24 |
| EPS Diluted Before Non-Recurring Items | -0.71 | -0.69 | -0.40 | 0.25 | N/A |
| EBITDA(a) | $-48,026 | $-50,704 | $-66,172 | $-42,464 | $-4,959 |